* ImmunoGen Inc., of Cambridge, Mass., raised $3 million in a sale of convertible preferred stock. The equity investment is part of a financing agreement negotiated in October 1996 with an institutional investor. The deal gives ImmunoGen the option of selling a total of $12 million worth of preferred stock through March 31, 1998. The company has raised $6 million under the agreement.

No Comments